awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37420530-A3C2F976-8BF8-4EB6-AFD8-A879E61131B8
Q37420530-A3C2F976-8BF8-4EB6-AFD8-A879E61131B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37420530-A3C2F976-8BF8-4EB6-AFD8-A879E61131B8
Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food.
P2860
Q37420530-A3C2F976-8BF8-4EB6-AFD8-A879E61131B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37420530-A3C2F976-8BF8-4EB6-AFD8-A879E61131B8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f466f637ce464b564bbc137393f3f20f990c6db2
P2860
Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment.